Clinical trial of LB-46 (d, 1-4-(2-hydroxy-3-isopropylaminopropoxy)indol. An adrenergic beta-receptor blocking agent in migraine prophylaxis (Q54314497): Preview

Clinical trial of LB-46 (d, 1-4-(2-hydroxy-3-isopropylaminopropoxy)indol. An adrenergic beta-receptor blocking agent in migraine prophylaxis (Q54314497)
scientific article published in April 1972

Language:

Current Data About Clinical trial of LB-46 (d, 1-4-(2-hydroxy-3-isopropylaminopropoxy)indol. An adrenergic beta-receptor blocking agent in migraine prophylaxis

(P31)

(Q13442814)

(P248)
(P698)	4402287
(P813)	Sunday, May 27, 2018
(P854)	http://europepmc.org/abstract/MED/4402287

(P304)

15-17

(P248)
(P698)	4402287
(P813)	Sunday, May 27, 2018
(P854)	http://europepmc.org/abstract/MED/4402287

(P407)

(Q1860)

(P433)

(P248)
(P698)	4402287
(P813)	Sunday, May 27, 2018
(P854)	http://europepmc.org/abstract/MED/4402287

(P478)

(P248)
(P698)	4402287
(P813)	Sunday, May 27, 2018
(P854)	http://europepmc.org/abstract/MED/4402287

(P577)

Saturday, April 1, 1972

(P248)
(P698)	4402287
(P813)	Sunday, May 27, 2018
(P854)	http://europepmc.org/abstract/MED/4402287

(P921)

(Q133823)

(P887)

(P1433)

(Q5689497)

(P248)
(P698)	4402287
(P813)	Sunday, May 27, 2018
(P854)	http://europepmc.org/abstract/MED/4402287

(P1476)

"Clinical trial of LB-46 (d, 1-4-(2-hydroxy-3-isopropylaminopropoxy)indol. An adrenergic beta-receptor blocking agent in migraine prophylaxis" (language: en)

(P248)
(P698)	4402287
(P813)	Sunday, May 27, 2018
(P854)	http://europepmc.org/abstract/MED/4402287

(P2093)

Ekbom K

(P1545)	1

(P248)
(P698)	4402287
(P813)	Sunday, May 27, 2018
(P854)	http://europepmc.org/abstract/MED/4402287

Lundberg PO

(P1545)	2

(P248)
(P698)	4402287
(P813)	Sunday, May 27, 2018
(P854)	http://europepmc.org/abstract/MED/4402287

other details

description	scientific article published in April 1972

External Links

(P356)	10.1111/J.1526-4610.1972.HED1201015.X
(P698)	4402287